Search research articles
Contact Us
Filters
Showing results (21-30 of 568) with videos related to
Page
of 57
Sort By:
The American Journal of Medicine
|
December 17, 2005
A rationale for combination therapy in risk factor management: a mechanistic perspective
R Preston Mason
Public Health
|
January 1, 1970
The future of the public health doctor. 2. The district medical officer
J R Preston
Drugs
|
May 7, 2008
Scientific rationale for combination of a calcium channel antagonist and an HMG-CoA reductase inhibitor: a new approach to risk factor management
R Preston Mason
Vascular Health and Risk Management
|
July 29, 2011
Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil
R Preston Mason
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
June 1, 1990
Genetic dissection of Ca2(+)-dependent ion channel function in Paramecium
R R Preston
Current Hypertension Reports
|
May 22, 2012
Pleiotropic effects of calcium channel blockers
R Preston Mason
The Body Positive
|
September 11, 2001
Setting goals for health and fitness. Small steps towards taking control of your life
G R Preston
Zhonghua Yi Xue Za Zhi
|
January 12, 2010
[Current treatment of pulmonary arterial hypertension]
Ioana R Preston
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
February 28, 2007
Adolescent smoking
Paul R Preston
The American Journal of Cardiology
|
November 28, 2006
Molecular basis of differences among statins and a comparison with antioxidant vitamins
R Preston Mason
Page
of 57
Search research articles
Search
Showing results (21-30 of 568) with videos related to
Sort By:
Page
of 57
The American Journal of Medicine
|
December 17, 2005
A rationale for combination therapy in risk factor management: a mechanistic perspective
R Preston Mason
Public Health
|
January 1, 1970
The future of the public health doctor. 2. The district medical officer
J R Preston
Drugs
|
May 7, 2008
Scientific rationale for combination of a calcium channel antagonist and an HMG-CoA reductase inhibitor: a new approach to risk factor management
R Preston Mason
Vascular Health and Risk Management
|
July 29, 2011
Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil
R Preston Mason
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
June 1, 1990
Genetic dissection of Ca2(+)-dependent ion channel function in Paramecium
R R Preston
Current Hypertension Reports
|
May 22, 2012
Pleiotropic effects of calcium channel blockers
R Preston Mason
The Body Positive
|
September 11, 2001
Setting goals for health and fitness. Small steps towards taking control of your life
G R Preston
Zhonghua Yi Xue Za Zhi
|
January 12, 2010
[Current treatment of pulmonary arterial hypertension]
Ioana R Preston
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
February 28, 2007
Adolescent smoking
Paul R Preston
The American Journal of Cardiology
|
November 28, 2006
Molecular basis of differences among statins and a comparison with antioxidant vitamins
R Preston Mason
Page
of 57